Last updated: June 12, 2026
Shire LLC v. Abhai LLC 1:15-cv-13909: Litigation Summary, Claims at Issue, and IP-Strength Takeaways
Shire LLC sued Abhai LLC in the US District Court for the District of Massachusetts under case number 1:15-cv-13909. The record is not provided here, and the decision history, asserted patents, claim constructions, infringement theories, defenses, and settlement/termination posture are not supplied. Without the docket text and case filings, a complete, accurate litigation summary and analysis cannot be produced.
What is the docket history for Shire LLC v. Abhai LLC 1:15-cv-13909?
No case timeline can be stated because the docket events (complaint filing date, service, motions, claim construction, summary judgment, trial, and final judgment/termination) are not included.
What were the key procedural milestones (complaint, MTC, Markman, summary judgment, final judgment)?
No milestone dates or rulings are available from the provided information.
Did the court decide any claim construction or dispositive motions?
No claim construction or dispositive outcomes are provided.
Which patents did Shire assert in Shire LLC v. Abhai LLC 1:15-cv-13909?
The asserted patent list and asserted claims are not included. Without patent numbers and claim groupings, infringement scope and validity exposure cannot be analyzed.
What were the infringement theories (composition, method of use, formulation, process/manufacturing)?
No asserted theories are provided.
What were Abhai’s defenses (noninfringement, invalidity, unenforceability, prosecution history estoppel)?
No defense details are provided.
How did the court treat the asserted claims and claim scope in Shire LLC v. Abhai LLC?
No Markman order, claim construction language, or infringement analysis is available.
What claim terms were construed and how did construction affect the case?
No construction information is provided.
Were any claims held not infringed or invalid at summary judgment?
No summary-judgment holdings are provided.
What is the litigation outcome and status for Shire LLC v. Abhai LLC?
No dispositive outcome is included (dismissal, settlement, consent judgment, default, summary judgment, or trial verdict).
Was there a settlement, consent judgment, or ongoing injunction?
No settlement or enforcement terms are provided.
Has the case been terminated, and what was the termination date?
No termination data is provided.
How strong is the Shire patent estate relative to Abhai’s product exposure in 1:15-cv-13909?
No product-identification, labeling, ANDA/BLA posture, or asserted-claim mapping is provided. Without that, patent-strength analysis is not possible.
What generic or competing product was at issue and what FDA pathway did it use?
No FDA pathway or product information is provided.
Were Paragraph IV challenges involved and did any Hatch-Waxman exclusivity drive the case?
No Hatch-Waxman details are provided.
What patent infringement risks does this case create for Abhai or other entrants?
No holdings or even asserted claim scope is available, so risk quantification cannot be stated.
What injunction or design-around guidance emerged from the litigation?
No injunction language or guidance is provided.
Did the case identify manufacturing, formulation, or process barriers?
No manufacturing/process findings are provided.
Key Takeaways
- A litigation summary and analysis for Shire LLC v. Abhai LLC (1:15-cv-13909) cannot be produced from the information provided, because the docket history, asserted patents, claim constructions, rulings, and outcome are not included.
FAQs
-
What patents were asserted in Shire LLC v. Abhai LLC (1:15-cv-13909)?
Not provided.
-
Did the court issue a Markman (claim construction) order in 1:15-cv-13909?
Not provided.
-
What was the final disposition of the case (settlement, dismissal, judgment)?
Not provided.
-
Were any Hatch-Waxman Paragraph IV allegations tied to the asserted patents?
Not provided.
-
Does the case mention an Orange Book listing or FDA approval tied to the dispute?
Not provided.
References
No sources cited because no case record details were provided.